Why Moderna Won T Share Covid 19 Vaccine Patent Rights With The U S Government Which Paid For Its Development
A quiet months-long legal fight between the U.S. National Institutes of Health and drugmaker Moderna over COVID-19 vaccine patents recently burst into public view. The outcome of the battle has important implications, not only for efforts to contain the pandemic but more broadly for drugs and vaccines that could be critical for future public health crises. I teach drug regulation and patent law at Saint Louis University’s Center for Health Law Studies....